| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Concordance between expectations and preferences of patients and evaluation criteria of the European Medicines Agency
|
Gil-Sierra, Manuel David
|
|
|
46 |
3 |
p. 157-165
|
artikel
|
| 2 |
Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
|
Moreno-Martínez, Estela
|
|
|
46 |
3 |
p. 121-132
|
artikel
|
| 3 |
Evaluating board certification within international advance pharmacy practice frameworks
|
Lawson, Brian E.
|
|
|
46 |
3 |
p. 191-198
|
artikel
|
| 4 |
Fe de errores de «Farmacia Hospitalaria. 2021;45(3):126-34»
|
Tejedor-Tejada, Eduardo
|
|
|
46 |
3 |
p. 202
|
artikel
|
| 5 |
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
|
Montoro-Ronsano, José Bruno
|
|
|
46 |
3 |
p. 109-115
|
artikel
|
| 6 |
Inclusion of omalizumab in a trastuzumab desensitization protocol
|
Barreiro-Fernández, Ester María
|
|
|
46 |
3 |
p. 199-201
|
artikel
|
| 7 |
Medicines in exceptional circumstances for solid tumours: focusing on evidence, effectiveness, and toxicity profiles
|
Artiles-Medina, Alberto
|
|
|
46 |
3 |
p. 133-145
|
artikel
|
| 8 |
Patient-reported outcomes and mobile applications. A review of their impact on patients’ health outcomes
|
Collado-Borrell, Roberto
|
|
|
46 |
3 |
p. 173-181
|
artikel
|
| 9 |
Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients
|
Sulaiman, Helmi
|
|
|
46 |
3 |
p. 182-190
|
artikel
|
| 10 |
Precision medicine in chronic lymphatic leukemia: Cost-effectiveness analysis of the new targeted therapies
|
Briones, Javier
|
|
|
46 |
3 |
p. 103-104
|
artikel
|
| 11 |
Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital
|
Palomo-Palomo, Cristina
|
|
|
46 |
3 |
p. 152-156
|
artikel
|
| 12 |
Systematic review and meta-analysis of interleulin-6 inhibitors in reducing mortality for hospitalized patients with COVID-19
|
Alegre-del-Rey, Emilio Jesús
|
|
|
46 |
3 |
p. 166-172
|
artikel
|
| 13 |
The risk of treatment-induced QT interval prolongation
|
Chaverri-Fernández, José Miguel
|
|
|
46 |
3 |
p. 116-120
|
artikel
|
| 14 |
Use of tracking drugs for the search of intra-hospital adverse reactions: a pharmacovigilance study
|
Baesso, Kely Corrêa Benedet
|
|
|
46 |
3 |
p. 146-151
|
artikel
|
| 15 |
Vancomycin versus daptomycin for the treatment of confirmed gram-positive catheter-related bloodstream infections in oncology patients
|
Rosario-García, Betel del
|
|
|
46 |
3 |
p. 105-108
|
artikel
|
Tijdschrift beschrijving